Donald McCaffrey
Chief Executive Officer at RESVERLOGIX CORP.
Net worth: 613 356 $ as of 2024-03-30
Profile
Donald J.
McCaffrey is the founder.
He founded Resverlogix Corp.
in 2000, where he currently holds the titles of Chairman, President, CEO & Secretary.
He also founded Zenith Capital Corp.
(Alberta) in 2013, where he currently holds the titles of Chairman, President & Chief Executive Officer.
In addition to his founding positions, Mr. McCaffrey has held former positions as Director at Trillium Therapeutics ULC from 2004 to 2006, and as Director at ProMIS Neurosciences, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ZENITH CAPITAL CORP.
1.72% | 2024-01-01 | 2,615,324 ( 1.72% ) | 392 299 $ | 2024-03-30 |
RESVERLOGIX CORP.
1.93% | 2024-01-01 | 5,263,266 ( 1.93% ) | 221 057 $ | 2024-03-30 |
Donald McCaffrey active positions
| Companies | Position | Start |
|---|---|---|
| RESVERLOGIX CORP. | Chief Executive Officer | 2003-04-24 |
| ZENITH CAPITAL CORP. | Chief Executive Officer | 2013-04-09 |
Former positions of Donald McCaffrey
| Companies | Position | End |
|---|---|---|
| TRILLIUM THERAPEUTICS | Director/Board Member | 2006-03-26 |
| PROMIS NEUROSCIENCES, INC. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| RESVERLOGIX CORP. | Health Technology |
| ZENITH CAPITAL CORP. | Health Technology |
| PROMIS NEUROSCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
- Stock Market
- Insiders
- Donald McCaffrey
